Literature DB >> 21623755

The mesenchymal stem cell profile in psoriasis.

M Orciani1, A Campanati, E Salvolini, G Lucarini, G Di Benedetto, A Offidani, R Di Primio.   

Abstract

BACKGROUND: The expression of inducible nitric oxide synthase (iNOS) and vascular endothelial growth factor (VEGF) and the level of total oxyradical scavenging capacity have been evaluated extensively in the cutaneous cells of patients with psoriasis. As yet, no indications are available about the undifferentiated cells, the mesenchymal stem cells (MSCs), isolated from skin.
OBJECTIVES: To isolate MSCs in patients with psoriasis and to compare them with those obtained from atopic and healthy subjects, in order to analyse whether MSCs show some typical psoriatic profiles and to understand whether pathophysiological events leading to psoriasis start early at the stem cell level.
METHODS: MSCs isolated from seven patients with psoriasis, seven patients with acute atopic dermatitis and seven healthy subjects were characterized by fluorescence-activated cell sorting analysis. VEGF and nitric oxide (NO) content was measured in conditioned medium, the expression of VEGF and iNOS was analysed by immunohistochemistry, and the total oxyradical scavenging capacity towards peroxynitrite was tested.
RESULTS: VEGF content was highest in the medium conditioned by psoriatic perilesional MSCs, whereas NO concentration was maximally increased in medium conditioned by MSCs isolated from lesional psoriatic skin. The ability to neutralize the oxidizing effects of peroxynitrite was lower for MSCs isolated from lesional psoriatic skin compared with other MSCs, except for MSCs of lesional atopic skin.
CONCLUSIONS: The microenvironment in psoriasis differs from those of atopic dermatitis and healthy skin; it could induce resident MSCs to produce angiogenic and proinflammatory mediators which lead to a reduction in the antioxidant capacity of these cells, contributing to the development of skin lesions in psoriasis.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623755     DOI: 10.1111/j.1365-2133.2011.10438.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  16 in total

1.  New miRNAs network in human mesenchymal stem cells derived from skin and amniotic fluid.

Authors:  R Lazzarini; G Sorgentoni; M Caffarini; M A Sayeed; F Olivieri; R Di Primio; M Orciani
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

2.  Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.

Authors:  Shyam Kishor Sah; Kyung Ho Park; Chae-Ok Yun; Kyung-Sun Kang; Tae-Yoon Kim
Journal:  Antioxid Redox Signal       Date:  2015-11-18       Impact factor: 8.401

3.  Psoriasis beyond the skin surface: a pilot study on the ocular involvement.

Authors:  A Campanati; P Neri; K Giuliodori; I Arapi; G Carbonari; E Borioni; C P Herbort; C Mariotti; A Giovannini; A Offidani
Journal:  Int Ophthalmol       Date:  2014-05-06       Impact factor: 2.031

4.  Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors.

Authors:  M Orciani; S Davis; G Appolloni; R Lazzarini; M Mattioli-Belmonte; R A Ricciuti; M Boscaro; R Di Primio; G Arnaldi
Journal:  Cancer Gene Ther       Date:  2014-12-19       Impact factor: 5.987

5.  Indirect co-cultures of healthy mesenchymal stem cells restore the physiological phenotypical profile of psoriatic mesenchymal stem cells.

Authors:  A Campanati; M Orciani; G Sorgentoni; V Consales; M Mattioli Belmonte; R Di Primio; A Offidani
Journal:  Clin Exp Immunol       Date:  2018-05-31       Impact factor: 4.330

6.  Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa.

Authors:  Anna Campanati; Monia Orciani; Giulia Sorgentoni; Veronica Consales; Annamaria Offidani; Roberto Di Primio
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

7.  Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients.

Authors:  Kalil A de Lima; Gislane L V de Oliveira; Juliana N U Yaochite; Daniel G Pinheiro; Júlia T C de Azevedo; Wilson Araujo Silva; Dimas T Covas; Carlos E B Couri; Belinda P Simões; Julio C Voltarelli; Maria C Oliveira; Kelen C R Malmegrim
Journal:  Stem Cell Res Ther       Date:  2016-07-12       Impact factor: 6.832

8.  The effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasis.

Authors:  Anna Campanati; Monia Orciani; Giulia Ganzetti; Veronica Consales; Roberto Di Primio; Annamaria Offidani
Journal:  J Int Med Res       Date:  2016-09       Impact factor: 1.671

Review 9.  Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives.

Authors:  Anna Campanati; Veronica Consales; Monia Orciani; Katia Giuliodori; Giulia Ganzetti; Ivan Bobyr; Giulia Sorgentoni; Roberto di Primio; Annamaria Offidani
Journal:  Psoriasis (Auckl)       Date:  2017-11-27

10.  Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

Authors:  Giulia Ganzetti; Anna Campanati; Andrea Santarelli; Davide Sartini; Elisa Molinelli; Valerio Brisigotti; Giulia Di Ruscio; Ivan Bobyr; Monica Emanuelli; Annamaria Offidani
Journal:  J Int Med Res       Date:  2016-09       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.